What is Atrial Fibrillation?
 

Atrial Fibrillation (AFib) is the most common type of abnormal heart rhythm (arrhythmia). Normally, your heart beats in a steady, coordinated rhythm driven by electrical impulses that start in the upper chambers (atria) and move to the lower chambers (ventricles).
 

In AFib, the electrical signals in the atria become chaotic and disorganized. Instead of contracting smoothly to pump blood, the atria quiver rapidly and ineffectively. This prevents blood from emptying completely, causing it to pool—most notably in a small pouch called the Left Atrial Appendage (LAA). When blood pools, it can form clots that break loose, travel to the brain, and cause an ischemic stroke.

Common Causes & Risk Factors
 

AFib can be triggered by structural heart changes, electrical scarring, or systemic health conditions:
 

• High Blood Pressure (Hypertension): The leading underlying risk factor for developing AFib.

• Age & Genetics: Risk increases significantly with advancing age and a family history of arrhythmias.

• Heart Conditions: Heart failure, coronary artery disease, history of heart attacks, structural valve diseases, or cardiomyopathy.

• Systemic & Metabolic Issues: Obesity, diabetes, obstructive sleep apnea, hyperthyroidism, and chronic kidney disease.

• Lifestyle Factors: Excessive alcohol consumption ("holiday heart syndrome"), smoking, and severe physical or emotional stress.

Warning Signs & Common Symptoms
 

While some people experience "silent" AFib with no symptoms at all, others feel abrupt changes in their heart rhythm. Common warning signs include:
 

• Heart Palpitations: A fluttering, racing, pounding, or skipped heartbeat sensation in the chest.

• Fatigue & Exhaustion: Feeling overwhelmingly tired during routine daily tasks.

• Shortness of Breath: Breathlessness during light activity or while resting.

• Dizziness, Lightheadedness, or Fainting: Caused by the heart pumping less efficiently, reducing blood flow to the brain.

• Chest Discomfort: Pressure, aching, or pain in the chest area.

Risk Assessment: How Doctors Choose Stroke Prevention
 

To determine the best antithrombotic strategy, healthcare providers use a structured two-step clinical risk assessment:
 

Step 1: Assessing Stroke Risk (The CHA₂DS₂-VASc Score)

Clinicians calculate an annual stroke risk score based on clinical criteria:
 

• C - Congestive heart failure (1 pt)

• H - Hypertension (1 pt)

• A₂ - Age ge 75 years (2 pts)

• D - Diabetes mellitus (1 pt)

• S₂ - Stroke, TIA, or thromboembolism history (2 pts)

• V - Vascular disease (prior heart attack or plaque buildup) (1 pt)

• A - Age 65 to 74 years (1 pt)

• Sc - Sex category (Female) (1 pt)
  
  Guidance: Men with a score of ge 2 (or women with ge 3) are strongly recommended to start long-term oral anticoagulation. Anticoagulation may also be reasonable at intermediate risk (score 1 in men or 2 in women) after considering additional risk factors and patient preferences.

Step 2: Assessing Bleeding Risk (The HAS-BLED Score)

Once anticoagulation is indicated, providers evaluate bleeding risk using the HAS-BLED score:

• H - Uncontrolled hypertension (> 160 mmHg systolic) (1 pt)

• A - Abnormal renal or liver function (1 or 2 pts)

• S - Stroke history (1 pt)

• B - Bleeding history or predisposition (1 pt)

• L - Labile INR on warfarin (1 pt)

• E - Elderly (Age > 65 years) (1 pt)

• D - Drugs (concurrent antiplatelets/NSAIDs) or Alcohol excess (1 or 2 pts)
  
  Guidance: A high score (ge 3) does not automatically rule out blood thinners; instead, it triggers a plan to fix reversible risk factors (like controlling blood pressure or stopping unnecessary aspirin) while monitoring closely.

Pharmacotherapy & Interventions
 

• Oral Anticoagulants (Blood Thinners):

  • Direct Oral Anticoagulants (DOACs) – e.g., Apixaban (Eliquis): Modern first-line standard of care. They directly inhibit clotting factors to prevent strokes without requiring routine blood test monitoring. Dosage is adjusted based on kidney function and body weight.

  • Aspirin: Extensive clinical trials show it is significantly less effective than DOACs for AFib stroke prevention while carrying meaningful bleeding risks. It is generally reserved only for specific situations when anticoagulants are strictly contraindicated.

  • Warfarin: Still preferred for specific structural conditions, such as mechanical heart valves or moderate-to-severe mitral stenosis.

• Structural Interventions

  • Left Atrial Appendage Occlusion: A minimally invasive, catheter-delivered structural heart device by Abbott designed to physically seal off the left atrial appendage—the source of over 90% of stroke-causing clots. It serves as an alternative for patients who need stroke protection but cannot tolerate long-term blood thinners due to bleeding risks.

• Rate & Rhythm Control Medications:

  • Beta-blockers or Calcium Channel Blockers: To slow down a rapid ventricular response.

  • Antiarrhythmic Drugs: To help restore and maintain a normal sinus rhythm.

• Cardiac Ablation (Rhythm Restoration Procedure):

  • What it is: A minimally invasive procedure designed to scar or destroy tiny areas of heart tissue that are triggering or conducting the chaotic electrical signals causing AFib.

  • How it works: Electrophysiologists thread thin catheters through blood vessels up to the heart, using radiofrequency energy (heat) or cryoablation (extreme cold) to isolate the pulmonary veins (where most AFib triggers originate) and block abnormal electrical pathways.

  • Indications & Criteria: Commonly recommended for patients who have symptomatic paroxysmal or persistent AFib whose rhythms cannot be adequately controlled by antiarrhythmic medications, or as a preferred first-line rhythm-control option to improve quality of life, reduce symptom burden, and prevent long-term heart remodeling.

                                                            References & Guidelines
 

• American College of Cardiology/American Heart Association/American College of Clinical Pharmacy/Heart Rhythm Society (ACC/AHA/ACCP/HRS). 2023 Guideline for the Diagnosis and Management of Atrial Fibrillation.

• European Society of Cardiology (ESC). 2024 Guidelines for the Management of Atrial Fibrillation.

• Society for Cardiovascular Angiography & Interventions/Heart Rhythm Society (SCAI/HRS). Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure.

​